Comparison of four different ovarian stimulation protocols in an in vitro fertilisation & embryo transfer programme.
Four different ovarian stimulation protocols were evaluated in an in vitro fertilisation and embryo transfer programme in 208 women (228 treatment cycles). In the rigid protocol (RP), 100 mg of clomiphene citrate (CC) was given from day 3 to day 7 of the menstrual cycle and 300 IU of human menopausal gonadotropin (hMG) was given from day 5 of the menstrual cycle. In the individualised protocol (IP) the same drugs and doses were used as in RP, but the day of initiation of CC depended on the length of the individual's menstrual cycle and hMG was administered from the last day of CC. In the programmed protocol (PP), ovarian function was suppressed with oral contraceptive pills (ethinyl estradiol 30 micrograms and norethisterone 1 mg) started on day 5 of the menstrual cycle for 45 to 70 days. Considering the last day of pill intake as day 0, CC was given for 5 days from day 5 and hMG (300 IU) from day 7. In the alternate day protocol (ADP), 100 mg of CC was administered from day 2 to day 6 and hMG (300 IU) was given on alternate days from day 2 to day 8 or day 10 of the cycle. In all the women, hCG (5000 IU) was administered when the diameter of at least 2 follicles was greater than or equal to 16 mm and estradiol levels were 300 pg/ml/dominant follicle. Patients not showing such a response were not treated further. The cardinal events of IVF-ET such as number of good responders, incidence of oocytes harvested, fertilised and embryos transferred per cycle were compared and it was concluded that the pregnancy rates were highest in women treated by the PP.
Hinduja
I
I
Department of Obstetrics & Gynecology, King Edward Memorial Hospital, Bombay.
Mehta
R
R
Gopalkrishnan
K
K
Puri
C P
CP
Shah
J
J
Singh
V
V
Kumar
T C
TC
D000328:Adult; D002996:Clomiphene / Q000494:pharmacology*; D004624:Embryo Transfer; D004958:Estradiol / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D008596:Menotropins / Q000494:pharmacology*; D009865:Oocytes; D006080:Ovarian Follicle / Q000000981:diagnostic imaging; D010053:Ovary / Q000187:drug effects*; D013048:Specimen Handling; D014463:Ultrasonography
D002996:Clomiphene; D004958:Estradiol; D008596:Menotropins